Amzaleg Haim-Type 2 Diabetes-(Israeli)

Patient's Name: Amzaleg Haim
Gender: Male
Age: 54 years
Nationality: Israeli
Diagnosis: Type 2 Diabetes

Admission Status:
The patient has had type 2 diabetes for many years and has had multiple symptoms of polyuria and polydipsia. Currently, he took Dulaglutide (10mg daily) regularly, and also receives 30IU of Insulin Glargine injection daily and 1mg of Simpeglutide injection weekly. However, his blood glucose control was not satisfactory, and he continued to experience multiple symptoms of polyuria and polydipsia despite these measures.

Inpatient Examination:
The patient's blood pressure was 126/74 mmHg, and his heart rate was 78 beats per minute. He had a grayish complexion, dry skin, and poor nutrition. There was no inflammation in his pharynx. His respiratory sounds were clear in both lungs, and there were no dry or moist rales heard. His heart sounds were slightly low in pitch, with a regular rhythm, and there were no murmurs heard at any of the heart valve auscultation sites. His abdomen was flat and soft, and there was no palpable enlargement of the liver or spleen. The skin temperature of his distal lower legs and feet was low, with mild congestion and pigmentation. There was a dark and thick fungal infection in his toenails.

Neurological examination:
Patient is alert and speaking coherently. His mentality and cognitive functions are normal. There were no significant abnormalities noted in his cranial nerve examination. His muscle strength and tone in all four limbs were normal. Additionally, there was a decrease in the reflexes in his lower limbs, and the pathological reflexes were negative.

Please note the following blood test results:
His fasting blood sugar level was 9.3mmol/L, and his 2 hours post-dinner blood sugar level was 21.4mmol/L. His glycosylated hemoglobin level was 10.44g/dL, and his renal function test showed a Urea level of 9.7mmol/L (normal range is 3.1-8) and a CR level of 147.1umol/L (normal range is 57-97).

Treatment process:
The patient was admitted with a clear diagnosis of "type 2 diabetes". During his stay in the hospital, he received mesenchymal stem cell therapy to repair the pancreas and regulate the immune system, neural stem cell therapy to enhance nerves, endocrinology, and nutrition support, and adjuvant medication CAST treatment, along with comprehensive rehabilitation therapy.

Post-treatment:
The patient's blood sugar control has improved significantly. His fasting blood sugar is mostly between 5-7mmol/L, and his 2 hours post-dinner blood sugar is between 7-11mmol/L. The injection dosage of his Insulin Glargine dosage has gradually decreased, and his polyuria and polydipsia have improved. His complexion is noticeably flushed, and his lower limb skin blood circulation has significantly improved with near-normal skin temperature and skin color. His energy, physical stamina, and exercise endurance have all improved significantly. His renal function has returned to normal upon reexamination.